Company Filing History:
2 out of 1,595 
2 out of 1,997 
2 out of 874 
Years Active: 2016-2018
Title: Innovations of Jianmin Cui in KCNQ Channel Modulation
Introduction
Jianmin Cui is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of KCNQ channels. With a total of 2 patents, his work focuses on addressing critical health issues such as epilepsy, deafness, and arrhythmias.
Latest Patents
Cui's latest patents revolve around the therapeutic potential of KCNQ channels. The disclosures detail methods and compositions for modulating the activity of these channels to mitigate the effects of aberrant KCNQ channel function. This includes conditions like Long-QT syndrome (LQTS) and atrial fibrillation. The patents also highlight the discovery of specific regions of KCNQ channels that interact with channel-stimulating molecules such as ATP and PIP. Furthermore, the use of small molecules to modulate KCNQ channel activity in cells is emphasized, showcasing the therapeutic effects of these modulators.
Career Highlights
Throughout his career, Jianmin Cui has worked with prestigious institutions, including Washington University and the State University of New York. His research has significantly advanced the understanding of KCNQ channels and their role in various medical conditions.
Collaborations
Cui has collaborated with esteemed colleagues such as Ira S Cohen and Xiaoqin Zou, contributing to the depth and breadth of his research endeavors.
Conclusion
Jianmin Cui's innovative work in the modulation of KCNQ channels represents a significant advancement in therapeutic strategies for serious health conditions. His contributions continue to impact the field of biomedical research positively.